\-\ Texto\\:\\ \ \(0\)\
\-\ bilateral\\ papilledema\\,\\ left\\ greater\\ than\\ right\ \(1\)\
\-\ multiple\\ axial\\ mr\\ images\\ demonstrate\\ enlarged\\ optic\\ nerves\\ bilaterally\\,\\ with\\ stranding\\ of\\ intraconal\\ fat\\,\\ with\\ avid\\ enhancement\\ of\\ the\\ optic\\ nerves\\ and\\ the\\ surrounding\\ intraconal\\ fat\\ bilaterally\\ on\\ the\\ post\\-contrast\\ t1\\-weighted\\ images\\ with\\ fat\\-suppression\\,\\ without\\ fusiform\\ enlargement\\ of\\ the\\ nerves\\ or\\ tram\\-track\\-like\\ enhancement\\ seen\\ in\\ optic\\ glioma\\ or\\ optic\\ nerve\\ meningioma\\,\\ respectively\\.\\ \\ \ \(0\)\
\-\ mr\\ images\\ of\\ the\\ brain\\ \\(not\\ shown\\)\\ demonstrated\\ no\\ other\\ abnormalities\\.\ \(0\)\
\-\ optic\\ neuritis\ \(15\)\
\-\ optic\\ neuritis\\,\\ bilateral\\:\ \(1\)\
\-\ multiple\\ sclerosis\\ \\(initial\\ presentation\\)\ \(1\)\
\-\ acute\\ disseminated\\ encephalomyelitis\ \(7\)\
\-\ orbital\\ pseudotumor\ \(6\)\
\-\ 49\\ y\\.o\\.\\ white\\ man\\ who\\ had\\ an\\ acute\\ onset\\ of\\ bilateral\\ decreased\\ visual\\ acuity\\.\ \(1\)\
\-\ for\\ this\\ particular\\ patient\\,\\ his\\ male\\ gender\\,\\ the\\ fact\\ that\\ the\\ mri\\ of\\ the\\ brain\\ yielded\\ no\\ other\\ lesions\\ typical\\ for\\ ms\\,\\ and\\ the\\ bilateral\\ nature\\ of\\ the\\ optic\\ neuritis\\,\\ all\\ suggest\\ adem\\ \\(or\\ devic\\ disease\\,\\ nmo\\)\\ as\\ possible\\ etiology\\ for\\ his\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ optic\\:\\ 0\\.1668068803447818\ \(0\)\
\-\ neuritis\\:\\ 0\\.09784917546333148\ \(0\)\
\-\ nerves\\:\\ 0\\.07840087246063177\ \(0\)\
\-\ intraconal\\:\\ 0\\.07627243101419877\ \(0\)\
\-\ fat\\-suppression\\:\\ 0\\.05310553267449698\ \(0\)\
\-\ tram\\-track\\-like\\:\\ 0\\.05310553267449698\ \(0\)\
\-\ nmo\\:\\ 0\\.05310553267449698\ \(0\)\
\-\ bilateral\\:\\ 0\\.04997151154974564\ \(0\)\
\-\ devic\\:\\ 0\\.04341012356344818\ \(0\)\
\-\ yielded\\:\\ 0\\.036037982409098085\ \(0\)\
\-\ encephalomyelitis\\:\\ 0\\.03448479500366375\ \(0\)\
\-\ gender\\:\\ 0\\.03448479500366375\ \(0\)\
\-\ bilaterally\\:\\ 0\\.033815725765348234\ \(0\)\
\-\ avid\\:\\ 0\\.03347844509605431\ \(0\)\
\-\ \\-\\:\\ 0\\.03310352636219934\ \(0\)\
\-\ mr\\:\\ 0\\.03271324664995704\ \(0\)\
\-\ post\\-contrast\\:\\ 0\\.03241886276795995\ \(0\)\
\-\ acuity\\:\\ 0\\.03241886276795995\ \(0\)\
\-\ papilledema\\:\\ 0\\.03204223411144589\ \(0\)\
\-\ disseminated\\:\\ 0\\.03135301512844743\ \(0\)\
\-\ fat\\:\\ 0\\.0313121966612245\ \(0\)\
\-\ fusiform\\:\\ 0\\.031192363037591042\ \(0\)\
\-\ adem\\:\\ 0\\.03103588420383646\ \(0\)\
\-\ brain\\:\\ 0\\.030980138834973036\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.029785044656979565\ \(0\)\
\-\ his\\:\\ 0\\.0296733617788787\ \(0\)\
\-\ respectively\\:\\ 0\\.029660832083469105\ \(0\)\
\-\ images\\:\\ 0\\.029625251059325675\ \(0\)\
\-\ 49\\:\\ 0\\.02854205409675168\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.028243277342900042\ \(0\)\
\-\ particular\\:\\ 0\\.02759886698415204\ \(0\)\
\-\ enhancement\\:\\ 0\\.027596250194253446\ \(0\)\
\-\ ms\\:\\ 0\\.027512187842874333\ \(0\)\
\-\ fact\\:\\ 0\\.027096568135121617\ \(0\)\
\-\ acute\\:\\ 0\\.025420232880801148\ \(0\)\
\-\ stranding\\:\\ 0\\.024899922872543848\ \(0\)\
\-\ orbital\\:\\ 0\\.02441773788655869\ \(0\)\
\-\ nature\\:\\ 0\\.024366468671691767\ \(0\)\
\-\ other\\:\\ 0\\.02373058492412589\ \(0\)\
\-\ visual\\:\\ 0\\.023336602417814423\ \(0\)\
\-\ glioma\\:\\ 0\\.023208878275340912\ \(0\)\
\-\ suggest\\:\\ 0\\.021923907779473912\ \(0\)\
\-\ etiology\\:\\ 0\\.021789285498196826\ \(0\)\
\-\ multiple\\:\\ 0\\.02168440968047312\ \(0\)\
\-\ shown\\:\\ 0\\.020641245145481914\ \(0\)\
\-\ typical\\:\\ 0\\.020641245145481914\ \(0\)\
\-\ enlargement\\:\\ 0\\.020425110882440336\ \(0\)\
\-\ meningioma\\:\\ 0\\.01979571889430768\ \(0\)\
\-\ greater\\:\\ 0\\.019335640708858442\ \(0\)\
\-\ abnormalities\\:\\ 0\\.01890822061263986\ \(0\)\
\-\ nerve\\:\\ 0\\.01854786823185124\ \(0\)\
\-\ sclerosis\\:\\ 0\\.018489850803773165\ \(0\)\
\-\ or\\:\\ 0\\.01809980871621158\ \(0\)\
\-\ \\,\\:\\ 0\\.01793861879933832\ \(0\)\
\-\ presentation\\:\\ 0\\.017731329123440255\ \(0\)\
\-\ enlarged\\:\\ 0\\.01756398235171088\ \(0\)\
\-\ possible\\:\\ 0\\.01733724228243417\ \(0\)\
\-\ white\\:\\ 0\\.017072916944048302\ \(0\)\
\-\ initial\\:\\ 0\\.017057723754694627\ \(0\)\
\-\ surrounding\\:\\ 0\\.016922682315450393\ \(0\)\
\-\ disease\\:\\ 0\\.01682816314717716\ \(0\)\
\-\ onset\\:\\ 0\\.016249525457380423\ \(0\)\
\-\ decreased\\:\\ 0\\.015305761462196142\ \(0\)\
\-\ demonstrated\\:\\ 0\\.015104939653355225\ \(0\)\
\-\ y\\.o\\:\\ 0\\.014857707425221085\ \(0\)\
\-\ axial\\:\\ 0\\.014691514916071517\ \(0\)\
\-\ all\\:\\ 0\\.014559780056815005\ \(0\)\
\-\ lesions\\:\\ 0\\.013780484977975588\ \(0\)\
\-\ than\\:\\ 0\\.013488246113965506\ \(0\)\
\-\ who\\:\\ 0\\.013421496440612664\ \(0\)\
\-\ for\\:\\ 0\\.013176653288723767\ \(0\)\
\-\ \\(\\:\\ 0\\.013054729992358925\ \(0\)\
\-\ \\)\\:\\ 0\\.012895259496023586\ \(0\)\
\-\ man\\:\\ 0\\.012174288211385538\ \(0\)\
\-\ without\\:\\ 0\\.012120561243121447\ \(0\)\
\-\ demonstrate\\:\\ 0\\.011846097236946029\ \(0\)\
\-\ mri\\:\\ 0\\.011826962981413374\ \(0\)\
\-\ had\\:\\ 0\\.011107529031570532\ \(0\)\
\-\ no\\:\\ 0\\.01036679699643135\ \(0\)\
\-\ seen\\:\\ 0\\.010172455512455965\ \(0\)\
\-\ male\\:\\ 0\\.00930846709570767\ \(0\)\
\-\ that\\:\\ 0\\.008891450172041106\ \(0\)\
\-\ the\\:\\ 0\\.008328270162869024\ \(0\)\
\-\ as\\:\\ 0\\.007786611481289927\ \(0\)\
\-\ not\\:\\ 0\\.007438666697240575\ \(0\)\
\-\ an\\:\\ 0\\.007118463037859819\ \(0\)\
\-\ \\:\\:\\ 0\\.006808884433678705\ \(0\)\
\-\ this\\:\\ 0\\.005789983212735742\ \(0\)\
\-\ left\\:\\ 0\\.0057596702968247876\ \(0\)\
\-\ right\\:\\ 0\\.00543151631994227\ \(0\)\
\-\ patient\\:\\ 0\\.0051601923549180004\ \(0\)\
\-\ of\\:\\ 0\\.004912810877023608\ \(0\)\
\-\ on\\:\\ 0\\.004360789231117036\ \(0\)\
\-\ in\\:\\ 0\\.0025385375309653914\ \(0\)\
\-\ and\\:\\ 0\\.0021687832015929937\ \(0\)\
\-\ with\\:\\ 0\\.0021145333028293324\ \(0\)\
\-\ \\.\\:\\ 0\\.0010692631354622371\ \(0\)\
